News

Innovative Oncology Navigation Grant Program Announced

Innovative Oncology Navigation Grant Program Announced

Innovative Oncology Navigation Grant Announcement

The Academy of Oncology Nurse & Patient Navigators (AONN+) is thrilled to unveil a pioneering grant initiative in collaboration with Gilead Sciences. This exciting program aims to enhance oncology navigation, ultimately improving patient outcomes within healthcare systems.

Grant Program Objectives

The primary intent of this grant program is to foster the development, enhancement, and expansion of advanced tools that increase efficiency and elevate the essential role played by oncology navigators. Following AONN+'s recent call for grant submissions, healthcare professionals nationwide have responded with innovative ideas for applications, software solutions, and various improvements to healthcare systems.

Application and Funding Details

AONN+ is set to announce the recipients of the grant, which can be valued at up to $500,000, soon. The project work is anticipated to commence shortly after. The application process and implementation support for approved projects will also be facilitated by Amplity, AONN+'s reliable association management partner and strategic collaborator.

Leadership Remarks

"This funding mechanism demonstrates AONN+ and Gilead's commitment to tackling persistent issues faced in cancer care. We aim to empower navigators, enhance patient access to critical services, remove barriers to cancer treatment, and promote treatment adherence," stated Candice Roth, MSN, RN, CENP, Executive Director of AONN+. The utilization of navigators reveals substantial opportunities for optimizing patient healthcare outcomes, aiming to connect proposed tools with tangible improvements.

Gilead's Commitment to Oncology

As part of Gilead's Community Cancer Collective, the company expresses pride in partnering with AONN+ on this visionary initiative to support the oncology community. Darren Tayama, M.D., Vice President of US Medical Affairs in Oncology, emphasizes that together, they are paving the way for the future of cancer care through innovative oncology navigation solutions.

About the Academy of Oncology Nurse & Patient Navigators

The Academy of Oncology Nurse & Patient Navigators, Inc. (AONN+) stands as the leading national specialty organization focused on enhancing patient care and quality of life. By defining the role of oncology nurse and patient navigators, AONN+ has built a network for over 9,000 members since its inception in 2009. This organization plays a vital role in streamlining patient navigation and survivorship care services to navigate the challenges associated with cancer treatment.

About Gilead Sciences

Gilead Sciences, Inc. has dedicated over three decades to achieving breakthroughs in biopharmaceuticals, striving to create a healthier world. The company is committed to innovating medicines that combat life-threatening diseases such as HIV, viral hepatitis, COVID-19, cancer, and inflammation. Operating in more than 35 countries, Gilead’s headquarters is located in Foster City, California.

About Amplity

Amplity provides a range of medical and commercial services tailored to various stages of drug lifecycle management. As AONN+'s association management partner, Amplity has partnered continuously for 24 years in fulfilling the organization’s strategic objectives.

Contact Information

For more information, please reach out to Gwen Coverdale at 267-884-6328.

Frequently Asked Questions

What is the focus of the AONN+ and Gilead partnership?

The partnership focuses on improving oncology navigation and patient outcomes through a new grant program.

How much funding will be awarded through this grant program?

The grant program will provide up to $500,000 in funding for selected projects.

Who can apply for the grant program?

Healthcare leaders and organizations involved in oncology navigation can submit grant applications.

What role do oncology navigators play in cancer care?

Oncology navigators assist patients in accessing needed services, overcoming barriers, and ensuring adherence to treatments.

How can the public find more information about AONN+?

More information can be found through the Academy of Oncology Nurse & Patient Navigators’ official website.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Co-Diagnostics Nearing India TB Test Launch By 2026

Updated Category News Views 65

Co-Diagnostics Gears Up for Indian TB Test Market Picture this: Co-Diagnostics, a molecular diagnostics player, is on the brink of a significant leap toward expanding its footprint in India with its TB test. The stage is set, with a clinical study already turning in results as solid as old boots. We're talking sensitivity hovering around 97.3% and specificity at...

Continue Reading
Worldline Crowned as 2026 SPARK Matrix Leader

Updated Category News Views 68

Worldline's Journey to Leadership When you talk about the big dogs in payment services, Worldline’s name crops up for a reason. They've just snagged a top spot in the 2026 SPARK Matrix by the QKS Group, putting them in the limelight as a leader in Merchant Payment Platform technology. If you're in payments, this is worth a double take. The SPARK Matrix Breakdown The...

Continue Reading
Implantica's Strategic U.S. Entry with RefluxStop®

Updated Category News Views 50

Implantica's Ambitious Move into the U.S. Market Every now and then, a move in the medtech sector grabs everyone's attention, and that's what we got with Implantica's latest play. This company is pulling out the big guns to push its RefluxStop® device into the U.S. market—one of the toughest nuts to crack. They've roped in Dr. John C. Lipham, a leading U.S. surgeon, to...

Continue Reading
Class Action Lawsuit Hits Honor GMC & Hummer Hard

Updated Category News Views 35

Digging into the Allegations Against Honor GMC & Hummer Well, it looks like Honor GMC & Hummer is in hot water this week. The Zakay Law Group, a San Diego-based legal firm, has filed a class action complaint against the dealership giant, claiming they've been cutting corners where it matters most—paying their workers. What's the Beef? The suit levels some hefty...

Continue Reading
2026 World Laureates Forum Drives Science Forward

Updated Category News Views 69

A Meeting of Great Minds in Shanghai Alright, listen up. Shanghai's gearing up to be the nerve center for the 2026 World Laureates Forum (WLF), and it's seething with potential. This ain't your regular science fair; it's a lion's den of brainpower set to crack open the future of science and tech. With the heavy-hitters like Nobel and Turing laureates on the docket, you're...

Continue Reading
Flagstar Faces Heat: 9.2% Stock Drop Spurs Probe

Updated Category News Views 76

Flagstar's Descent: What Led to the Stock Tumble? And here we go again with a big name in finance taking a hit right between the eyes. Flagstar Bank, under ticker NYSE:FLG, saw its shares plummet by over 9.2% on October 23, 2026. This isn't just a blip—it's a spill. The backdrop here is an eye-watering $12.9 billion loan book tied to rent-regulated apartment buildings....

Continue Reading
Webull Faces Investor Lawsuit: Compliance in Question

Updated Category News Views 130

Webull's Run into Regulatory Fog Well, here we go—another tech company caught with its pants down over alleged ties with China. Webull Corporation (NASDAQ:BULL) is in the crosshairs of a class action lawsuit. Investors are sharpening their pitchforks, and you've got until December 7, 2026, to throw your hat in the ring as lead plaintiff. The Core of the Allegations...

Continue Reading
Japanese Hair Care Brand &honey Garners Top U.S. Award

Updated Category News Views 79

Hydration Reigns in Hair Care Here's something that'll make your average shampoo tremble in its plastic boots: Japan's &honey Deep Moist Shampoo has snagged the spot as Best Drugstore Shampoo for 2026, according to the Marie Claire Beauty Awards. It’s not some trivial title, folks. In a market flooded with every hair-elixir promise under the sun, getting this nod is...

Continue Reading
Baystate Health's Pilot Eases Access to Medical Services

Updated Category News Views 0

Rethinking Healthcare Access with Baystate Health Now here's a bit of news that doesn't make you wanna choke on your coffee: Baystate Health's Clear Path Pilot Program is shaking things up in the healthcare game, and it's about time. The initiative, rolling out with Health New England, is like waving a magic wand over the usual bureaucratic mess of prior authorizations....

Continue Reading
Vanda's NEREUS Outperforms in GLP-1 Vomiting Study

Updated Category News Views 32

A Surprising Breakthrough in Vomiting Prevention You don't need to be an old hand on Wall Street to see that when a biotech company rolls out positive trial results, ears perk up. Today, Vanda Pharmaceuticals' announcement that their NEREUS™ (tradipitant) drug aced Study 3601 is catching more eyes than initially expected. It's not just about hitting numbers; it's about...

Continue Reading

Top 5 Most Recently Viewed Articles

Replimune Group Faces Class Action Lawsuit Amid FDA Setback

Updated Category News Views 184

Replimune Group Faces Class Action Lawsuit Amid FDA Setback Pomerantz LLP has brought attention to a class action lawsuit involving Replimune Group, Inc. (NASDAQ: REPL). This legal action is relevant for investors who have experienced losses on their investments in the company. It's crucial for affected investors to be proactive and consider their options as they navigate...

Continue Reading
ARGAN Reports Major Carbon Emission Reductions in 2025

Updated Category News Views 323

Embracing Sustainability: ARGAN's 2025 ESG Report Highlights ARGAN, a leader in the development and rental of premium warehouses, has recently published its 2025 ESG report, showcasing remarkable achievements in sustainability and environmental stewardship. The report outlines a significant 25% reduction in CO2 emissions associated with energy consumption in their...

Continue Reading
Feedonomics Enhances YouTube Shopping With Strategic Partnership

Updated Category News Views 55

Feedonomics Partners with YouTube for Shopping Program Feedonomics has announced an exciting new partnership with YouTube that aims to boost the YouTube Shopping affiliate program. This collaboration focuses on providing robust product listing services and data optimization for merchants who participate in this rapidly growing online shopping platform. Streamlining...

Continue Reading
BJ's Wholesale Club Achieves Record High Stock Value of $92.38

Updated Category News Views 89

BJ's Wholesale Club Stock Breaks Records In an impressive show of market confidence, BJ's Wholesale Club Holdings Inc (NYSE: BJ) has celebrated a remarkable achievement as its stock surged to an all-time high, reaching a price of $92.38. This remarkable progression highlights the company’s ongoing growth and a substantial yearly change of 39.83% in stock price....

Continue Reading
Conduent's Upcoming Earnings: What Investors Should Know

Updated Category News Views 133

Conduent's Earnings Announcement Insights Conduent (NASDAQ: CNDT) will be sharing its quarterly earnings report soon. This announcement is essential for investors who are keen to understand the company's performance in detail. What Analysts Expect Analysts are currently estimating an earnings per share (EPS) of $-0.07 for Conduent. These figures are formulated based on...

Continue Reading